Johnson & Johnson news and events in 2026
Johnson & Johnson is a multinational corporation that develops pharmaceutical treatments and medical technology. The organization focuses on biotechnology and the creation of medical devices to treat and prevent complex diseases.
Get Johnson & Johnson's live signals in Claude or ChatGPT, or by API
What changed at Johnson & Johnson this week? Use Autobound signals for jnj.com.- Dated updates
- 88
- Last event
- Nov 17, 2026
- Open rolesSnapshot Nov 17, 2026
- 693
- Latest SEC filing
- Oct 21, 2026
Source: Autobound Signal API · 88 signals tracked for Johnson & Johnson · updated
Overview
Johnson & Johnson by topic
110-K filing
693open roles
50+signals
34 in the last 90 days
- Glassdoor15+
- Patents12
- LinkedIn11
- Reddit5
- and 2 more sources
Latest events
Latest Johnson & Johnson events
Showing 10 of 31 events. The Signal API returns all of them.
Get them with one API call- PartnershipJ&J to acquire eye disease-focused biotech firm Ollin Biosciences for up toWith Blackstone Life Sciences
- FundingJ&J Secures $750 Million in Blackstone R&D Funding, Pending Ollin ClosingJohnson & Johnson secured $750 million in R&D funding from Blackstone Life Sciences for Phase 3 development of OLN324, contingent on closing its Ollin acquisition.
- AcquisitionJohnson & Johnson to Acquire Ollin Biosciences for Up to $3.3 BillionJohnson & Johnson has agreed to acquire Ollin Biosciences for $2.2 billion upfront and up to approximately $1.1 billion in milestone payments.
- InvestmentJohnson & Johnson Stock: New Investments in Cancer and PsychiatryWith Francis Medical
- Integration
- In developmentJohnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancerJohnson & Johnson is developing an investigational dual-antigen immunotherapy combination of pasritamig and JNJ-9401 for the treatment of advanced prostate cancer, with the regimen entering Phase 3 development.
- In developmentJohnson & Johnson announces ICOTYDE® (icotrokinra) delivers significant improvement in psoriatic arthritis disease activity among biologic-naive patients with once-daily...Johnson & Johnson announced positive Phase 3 results for its investigational targeted oral peptide ICOTYDE (icotrokinra) in treating biologic-naive adults with active psoriatic arthritis.
- In developmentRYBREVANT®▼ (amivantamab) subcutaneous demonstrates a 77 percent objective response rate in first-line treatment for patients with certain advanced forms of head and neck cancerJohnson & Johnson released results from the Phase 1b/2 OrigAMI-4 study and expanded the clinical development of subcutaneous RYBREVANT (amivantamab) for head and neck cancer.
- In developmentRYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancerJohnson & Johnson is developing subcutaneous amivantamab and hyaluronidase-lpuj (RYBREVANT FASPRO) in ongoing Phase 1b/2 and Phase 3 clinical studies for advanced head and neck cancer.
- In developmentJohnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancerJohnson & Johnson announced Phase 3 PROTEUS substudy results evaluating the investigational use of ERLEADA (apalutamide) plus androgen deprivation therapy before and after surgery in high-risk prostate cancer.
Showing 10 of 31 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Johnson & Johnson with the Signal API
One POST /v1/companies/enrich call with jnj.com returns every signal type for Johnson & Johnson, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"jnj.com","limit":20}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Companies related to Johnson & Johnson
Johnson & Johnson questions
What is the latest news on Johnson & Johnson?
What is going on with Johnson & Johnson?
Is Johnson & Johnson laying off employees?
Has Johnson & Johnson announced any acquisitions?
What else does Autobound track for Johnson & Johnson?
Is Johnson & Johnson hiring right now?
Page updated , the date of the newest row on this page.
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .